Be the first person to write a business review for IVAX Diagnostics, Inc.

Kensey Nash Corporation operates as a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The company specializes in the product development and for applying unique technology in the field of resorbable biomaterials. It offers a range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopaedic, sports medicine, spine, endovascular, and general surgery markets. Kensey Nash Corporation was incorporated in 1984 and is headquartered in Exton, Pennsylvania.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company’s endovascular products include LeverEdge contrast injector for injection of contrast media into blood vessels; TAArget thoracic stent graft for use in the endovascular repair of thoracic aortic aneurysm and dissection; the UnBalloon non-occlusive modeling catheter for improvement in the seal of aortic stent grafts; and VascuTape radiopaque tape for improvement in precision of vascular and endovascular procedures. Its vascular products consist of AlboGraft vascular grafts for in bypass and replacement procedures; AlboSure and XenoSure vascular patches for use in closing incisions in a blood vessel; AnastoClip vessel closure system for attaching blood vessels primarily for dialysis access; EndoRE remote endarterectomy devices for removal of blockages in the arteries of the leg; expandable LeMaitre valvulotome for destruction of vein valves to create vein bypass grafts; InvisiGrip vein stripper for single-incision removal of varicose veins; LeMaitre balloon catheters for removal of blood clots, occlusion, and facilitation of blood flow; and Pruitt-Inahara, Pruitt F3, and Flexcel carotid shunts for facilitating blood flow to brain during carotid plaque removal. LeMaitre Vascular company’s products in general surgery category comprise reddick cholangiogram catheter for introduction of dye into the cystic duct; and OptiLock implantable port for central venous infusion of drugs and nutrients. In addition, LeMaitre distributes Powerlink system, a bifurcated abdominal stent graft, as well as engages in private label manufacturing. It sells its products through direct sales force and a network of distributors. LeMaitre Vascular was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Linkwell Corporation, through its subsidiaries, engages in the development, manufacture, sale, and distribution of disinfectant health care products primarily to the medical industry in China. It offers disinfectant products for various applications, such as skin and mucous membrane disinfectants, hand disinfectants, environment and surface disinfectants, medical devices and equipment disinfectants, machine disinfectants, and animal disinfectants. Linkwell Corporation provides its products in liquids and gel, tablets and powder, aerosol, chemical indicator, foam, and disinfectant appliance forms. It also sells products that are developed and manufactured by third parties. Linkwell Corporation’s customers include hospitals, medical suppliers, and distribution companies. Linkwell Corporation was founded in 1988 and is based in Shanghai, China.

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences and diagnostic industries in the United States. It offers xMAP technology, an open architecture and multiplexing technology, which allows simultaneous analysis of up to 500 bioassays from a single drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company’s xMAP technology is used in various segments of the life sciences industry, which includes the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, protein analysis, and biomedical research. It operates in two segments, Technology and Assay. The Technology segment offers instruments, such as compact analyzers that integrate fluidics, optics, and digital signal processing, as well as peripheral components; FLEXMAP 3D system for use as a general laboratory instrument in life science research and diagnostics markets; and consumables comprising microspheres and sheath fluid. The Assay segment involves in the development and sale of assays on xMAP technology for use on Luminex’s installed base of systems. It offers various assay products, which consists of a combination of chemical and biological reagents, and the company’s proprietary bead technology used to perform diagnostic and research assays on samples. Luminex Corporation serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions. It has a collaboration agreement with Northrop Grumman Corporation. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Lyall Willis was formed in 1898 and became a UK Ltd Company in 1920 primarily dealing in the export of UK manufactured goods. Lyall Willis & Co. Ltd. later moved its focus to becoming suppliers and distributors of Surgical Instruments, Diagnostic devices as well as Medical and scientific Instrumentation. Over the years Lyall Willis Surgical has built up considerable experience in the healthcare market specifically relating to its extensive range of Surgical Instruments and Diagnostic devices. To develop the UK market Lyall Willis offered a customer orientated service to medical trade companies throughout the UK as well as the NHS Trusts. Most of our sales and marketing is carried out through the instrument trade and distributors. Lyall Willis Surgical has become well known for stocking over 2,000 different types of surgical instruments available for next day despatch throughout the UK. With a total stock of over 400,000 surgical instruments, Lyall Willis surgical is able to respond quickly to customer demand and always strives to deliver more than 98% of orders on time and in full.We hold a current ISO 9001:2008, ISO 13485:2003, MDD 92/43/EEC certification and mark all our instruments with "CE" Mark and MDA Registration number "CA 001080". We also supply our own branded Sphygmomanometers marked with our registration number 0473. All surgical instruments are made from the highest-grade quality stainless steel to meet the requirements of BS 5194 part 1-4. We also supply bespoke surgical instruments where required by our customers. Furthermore Lyall Willis Surgical has expanded its operations into the supply of Single Use Sterile Surgical Instruments and Procedure Packs including Drapes. We have set up our own Clean Room Facility at our Factory in Bexhill-on-sea. Further additions to our scope include diagnostic devices such as Sphygmomanometers, Stethoscopes, Hammers, Tuning Forks, Laryngoscopes, and currently we have been successful on both Re-Usable and Single Use Framework Agreements and are suppliers to numerous NHS Supply Chain Contracts.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.